BNET Industries
Market Cap:$865.7M
Last Fiscal Year Sales:$139.6M
- Public
- US
Dow Jones Description
Meridian is a fully-integrated life science company whose principal businesses are (i) the development, manufacture, sale and distribution of diagnostic test kits, primarily for certain respiratory, gastrointestinal, viral and parasitic infectious diseases, (ii) the manufacture and distribution of bulk antigens, antibodies, and reagents used by researchers and other diagnostic manufacturers and (iii) the contract development and manufacture of proteins and other biologicals for use by biopharmaceutical and biotechnology companies engaged in research for new drugs and vaccines. By exploiting revenue opportunities across research, clinical diagnostics, and therapeutics, we strive to maximize revenues, efficiently invest in research and development, and increase profitability of our manufacturing operations. The company was incorporated in Ohio in 1976.
Chief Executive Officer
John A. KraeutlerNumber of Employees 396
Contact Information
3471 River Hills Dr
Cincinnati, Ohio 45244-3023
(513) 271-3700
Peer Companies
NAICS Code In-Vitro Diagnostic Substance Manufacturing: 325413
Recent Events
-
Flu test sales boost Meridian 3Q profit 16 percent
-
Meridian to distribute GI disease test in Italy
-
Meridian offers guidance for FY 2010
-
Meridian Bioscience names new board member
-
Swine flu tests boost Meridian
News & Analysis
Filter by
healthcare and meridian bioscience inc. - All News and Analysis
Meridian: A Timely Stock to Consider
Robert Freedland submits: As I slowly gain some confidence in this difficult stock market, I wanted to take another look at one of my past favorites, Meridian Bioscience VIVO. I do not currently own any shares, but have owned shares on an off since first writing...
Stock Checkup: Meridian Bioscience (VIVO)
Arsuron Papartassee submits: I wrote about Meridian Bioscience VIVO on April 7, 2009. This stock was trading at $16.90 then with an excellent yield of 4%. The stock has moved up 27% since and closed today at $21.60. I do not have any explanation for this movement except...
Meridian Biosciences: A Strong Long Term Investment
Dividend Inc. submits: As I mentioned in my sell recommendation of Helmerich and Payne HP, I have been anticipating the opportunity to buy Meridian Biosciences VIVO for over 3 years now. According to Morningstar.com, VIVO, "...manufactures disposable immunodiagnostic test kits used for the rapid diagnosis of infectious diseases. Its...
Meridian Bioscience to Present at the Sidoti & Company, LLC Twelfth Annual New York Emerging Growth Institutional Investor Forum
CINCINNATI -- Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ: VIVO) today announced that the Company has been invited to present at the Sidoti & Company, LLC Twelfth Annual New York Emerging Growth Institutional Investor Forum at The Hyatt Regency Hotel in New York. Jack Kraeutler, Chief Executive Officer, is scheduled to...
Meridian Bioscience to Present at the Robert W. Baird 2007 Growth Stock Conference
CINCINNATI -- Meridian Bioscience, Inc. (NASDAQ:VIVO) today announced that the Company has been invited to present at the Robert W. Baird 2007 Growth Stock Conference on Thursday, May 10, 2007 at 12:35 p.m. CDT at the Four Seasons Hotel in Chicago. Bill Motto, Chairman and Chief Executive Officer and Jack...
- 1
Decision Makers
| Name (plus bio) | Position |
|---|---|
| John A. Kraeutler | Chief Executive Officer |
| Melissa Lueke | Vice President and Chief Financial Officer |
| Lawrence J. Baldini | Executive Vice President, Operations & Is |
| Richard L Eberly | Executive Vice President, President Meridian Life Sc |
| Antonio A. Interno | Senior Vice President |
| Susan D. Rolih | Senior Vice President, Regulatory Affairs & Quality Assurance |
| Grady Barnes | Vice President, R & D |
| Gregory S. Ballish | Vice President, Sales and Marketing |
| Kenneth J. Kozak | Vice President, Research and Development |
| Todd W. Motto | Vice President, Sales and Marketing |
| Brenda Hughes | Manager, Investor Relations |
| David C. Philips | Director |
Board of Directors
| Name (plus bio) | Position |
|---|---|
| William J. Motto | Chairman of the Board and Chief Executive Officer |
| Robert J. Ready | Chairman of the Board and President, Lsi Industries, Inc. |
| David C. Phillips | Chairman |
| Gary P Kreider | Board of Directors |
| James A. Buzard | Board of Directors |
| James M. Anderson | Board of Directors |
| Organization | Position | Status |
|---|---|---|
| Al-Hayat Pharmaceuticals, Uae | Chief Executive Officer | Current |
| Meridian Bioscience Inc. | Chief Executive Officer | Current |
| Meridian Bioscience Inc. | President | Current |
| Dan Beard Council | Board of Directors | Current |
| Meridian Bioscience Inc. | Board of Directors | Current |
| Meridian Bioscience Inc. | Chief Operating Officer | Current |
| Organon Inc. | Former |
William J. Motto has more than 40 years of experience in the pharmaceutical and diagnostics products industries, is the founder of Meridian and has been Chairman of the Board since 1977. Before forming Meridian, Mr. Motto served in various capacities for Wampole Laboratories, Inc., Marion Laboratories, Inc. and Analytab Products, Inc., a division of American Home Products Corp.
| Organization | Position | Status |
|---|---|---|
| Meridian Bioscience Inc. | Chairman of the Board and Chief Executive Officer | Current |
| Wampole Laboratories | Former | |
| Marion Laboratories | Former | |
| Meridian Bioscience Inc. | Board of Directors | Former |
Robert J. Ready has been a director since 1986. Mr. Ready serves as Chairman of the Nominating Committee.Mr. Ready founded LSI Industries Inc., Cincinnati, Ohio in 1976, which engineers, manufactures and markets commercial/industrial lighting and graphics products, and has served as its President and Chairman of its Board of Directors since that time.
| Organization | Position | Status |
|---|---|---|
| Meridian Bioscience Inc. | Chairman of the Board and President, Lsi Industries, Inc. | Current |
| Ohio.Com | Founder | Former |
| Cincinnati, Ohio | Founder | Former |
| LSI Industries Inc. | Founder | Former |
| Verizon Communications Inc. | Former | |
| Meridian Bioscience Inc. | Board of Directors | Current |
Melissa A. Lueke has more than 23 years of finance experience and joined Meridian in January 1999 as U.S. Area Controller. She was appointed Vice President, Chief Financial Officer and Secretary in January 2001. Before joining Meridian, Ms. Lueke was Senior Audit Manager at Arthur Andersen LLP.
| Organization | Position | Status |
|---|---|---|
| Meridian Bioscience Inc. | Vice President and Chief Financial Officer | Current |
| Meridian Bioscience Inc. | Board of Directors | Current |
Lawrence J. Baldini has more than 28 years of experience in the industry and joined Meridian as Vice President Operations in April 2001. Before joining Meridian, Mr. Baldini was Director of Operations (Sensory Systems) at Instrumentation Laboratories where he previously held the title of Operations Manager and Facilities Manager. Mr. Baldini was appointed Executive Vice President, Operations and Information Systems in October 2005.
| Organization | Position | Status |
|---|---|---|
| Meridian Bioscience Inc. | Executive Vice President, Operations & Is | Current |
| Meridian Bioscience Inc. | Vice President, Operations | Current |
Richard L. Eberly has more than 22 years of experience in the industry and joined Meridian in March 1995 as Marketing Product Manager. Mr. Eberly previously held titles of Director of Sales and Vice President of Sales and Marketing. He was appointed Executive Vice President in May 2000 and President of Meridian Life Science in October 2005. Before joining Meridian, Mr. Eberly held various positions in Sales and Marketing at Abbott Diagnostics, Division of Abbott Laboratories.
| Organization | Position | Status |
|---|---|---|
| Meridian Bioscience Inc. | Executive Vice President, President Meridian Life Sc | Current |
| Dxma | Executive Vice President | Current |
| Meridian Bioscience Inc. | Vice President of Sales and Marketing | Current |
| Meridian Bioscience Inc. | Marketing Product Manager | Current |
| Dxma | Board of Directors | Current |
| Meridian Bioscience Inc. | Director of Sales | Former |
| Abbott Laboratories | Former | |
| Abbott Diagnostics | Former | |
| Xavier University | Mba Degree | Former |
| Juniata College | Undergraduate Degree In Biochemistry | Former |
Antonio Interno has more than 31 years of experience in the industry. Mr. Interno was appointed as a Vice President of Sales and Marketing in August 1991, appointed a Senior Vice President in September 1997, and appointed as President, Managing Director of Meridian Bioscience Europe in October 2003. He has been Managing Director of Meridian’s European subsidiaries, Meridian Bioscience Europe since February 1990.
| Organization | Position | Status |
|---|---|---|
| Meridian Bioscience Inc. | Senior Vice President | Current |
Array
| Organization | Position | Status |
|---|---|---|
| Meridian Bioscience Inc. | Senior Vice President, Regulatory Affairs & Quality Assurance | Current |
| Immucor, Inc. | President, Regulatory Affairs and Quality Assurance | Former |
| Immucor, Inc. | Vice President | Former |
Grady Barnes has more than 23 years of experience in the industry and joined Meridian in May 2007 as Vice President, Research and Product Development. Before joining Meridian, Dr. Barnes was Program Director of OEM Product Development in the Diagnostic Division of Abbott. While at Abbott, Dr. Barnes held various positions in R&D and product development for both assays and automated systems.
| Organization | Position | Status |
|---|---|---|
| Meridian Bioscience Inc. | Vice President, R & D | Current |
Gregory S. Ballish has more than 21 years of experience in the pharmaceutical and diagnostic industry and joined Meridian in January 2004 as Vice President, Sales and Marketing. Before joining Meridian, Mr. Ballish held senior sales management and strategic customer marketing roles with Janssen Pharmaceutica (Johnson & Johnson subsidiary).
| Organization | Position | Status |
|---|---|---|
| Meridian Bioscience Inc. | Vice President, Sales and Marketing | Current |
| Johnson & Johnson | Former | |
| Janssen Pharmaceutica | Former |
Kenneth J. Kozak has more than 26 years of experience in the healthcare industry and joined Meridian in October 1987 as Senior Research Associate. Mr. Kozak previously held titles of Manager, Senior Scientist, and Director, Product Development. He was appointed Vice President, Research and Development in May 1999. Before joining Meridian, Mr. Kozak held various Research Assistant positions at the University of Cincinnati College of Medicine.
| Organization | Position | Status |
|---|---|---|
| Meridian Bioscience Inc. | Vice President, Research and Development | Current |
| Meridian Bioscience Inc. | Senior Research Associate | Current |
| University of Cincinnati College of Medicine | Former |
Todd W. Motto has more than 15 years experience in the industry and joined Meridian as a Marketing Product Manager in July 1993. Mr. Motto has also held positions in Field Sales, Business Development and most recently as Vice President of Sales and Marketing for Meridian's European subsidiary, Meridian Bioscience Europe. Mr. Motto was appointed Vice President of Sales and Marketing of Meridian Bioscience, Inc. in October of 2005.
| Organization | Position | Status |
|---|---|---|
| Meridian Bioscience Inc. | Vice President, Sales and Marketing | Current |
| Meridian Bioscience Inc. | Marketing Product Manager | Current |
| Organization | Position | Status |
|---|---|---|
| Meridian Bioscience Inc. | Manager, Investor Relations | Current |
David C. Phillips has been a director since 2000. Mr. Phillips serves as Chairman of the Audit Committee. Mr. Phillips spent 32 years with Arthur Andersen L.L.P. His service with this firm included several managing partner leadership positions. After retiring from Arthur Andersen in 1994, Mr. Phillips became Chief Executive Officer of Downtown Cincinnati, Inc., which is responsible for economic revitalization of Downtown Cincinnati. Mr. Phillips retired from DCI in 1999 to devote full time to Cincinnati Works, Inc., an organization dedicated to reducing the number of people living below the poverty level by assisting them to strive towards self-sufficiency through work, and his financial consulting services. Mr. Phillips serves as a director of Cintas Corporation and Summit family of Mutual Funds.
| Organization | Position | Status |
|---|---|---|
| Meridian Bioscience Inc. | Chairman | Current |
| River Cities Capital Funds | Board of Directors | Current |
| Summit Family | Director | Current |
| Cintas Corporation | Board of Directors | Current |
| Confidential Materials Destruction, Inc | Member of the Audit Committee of the Board of Directors, Member of the Nominating | Current |
| Docuguides, Inc | Member of The Audit Committee of The Board of Directors, Member of The Nominating | Current |
| Downtown Cincinnati, Inc. | Chief Executive Officer | Former |
| Cintas Corporation | Elected A Director | Former |
| Meridian Bioscience Inc. | Director | Former |
| Organization | Position | Status |
|---|---|---|
| Meridian Bioscience Inc. | Director | Current |
| Meridian Bioscience Inc. | Founder | Former |
Gary P. Kreider Senior Partner Keating Muething & Klekamp PLL Age: 69 Director since: 2002 Committee Membership: Compensation Committee, Nominating & Corporate Governance Committee Term of Office Expires: 2008 Business Experience: Mr. Kreider has been a Director since April 2002. He is a senior partner in the Cincinnati law firm of Keating, Muething & Klekamp PLL, the Company’s outside counsel. His primary practice areas are securities law, mergers and acquisitions, and general corporate law, and he has been with Keating, Muething & Klekamp PLL, since 1963. Mr. Kreider has been an Adjunct Professor of Law in securities regulation at the University of Cincinnati College of Law since 1977 and is Chairman of the Ohio State Bar Association Corporate Law Committee. Directorships: Meridian Bioscience, Inc.
| Organization | Position | Status |
|---|---|---|
| LSI Industries Inc. | Senior Partner, Keating Muething & Klekamp Pll | Current |
| Al-Hayat Pharmaceuticals, Uae | Current | |
| Keating Muething & Klekamp PLL | Current | |
| Meridian Bioscience Inc. | Board of Directors | Current |
| LSI Industries Inc. | Director | Current |
| University of Cincinnati College of Law | Adjunct Professor | Former |
| FINRA | arbitrator | Former |
| Organization | Position | Status |
|---|---|---|
| Al-Hayat Pharmaceuticals, Uae | Current | |
| Meridian Bioscience Inc. | Board of Directors | Current |
| Marion Merrell Dow | Vice President | Former |
| Organization | Position | Status |
|---|---|---|
| Meridian Bioscience Inc. | Board of Directors | Current |
Executive News
-
LSI Industries Inc. Completes Acquisition of AdL Technology and Related Companies
-
Meridian Bioscience names new board member
-
Swine flu tests boost Meridian
-
Meridian Bioscience Appoints James M. Anderson to Board of
-
Meridian names James Anderson to board
-
FORTUNE Small Business Again Lists Meridian Bioscience as One of America's Fastest-Growing...
-
FORTUNE Small Business Again Lists Meridian Bioscience as One of Americas Fastest-Growing Small Companies
-
LSI wins major contract; will buy ADL Technology
-
LSI wins major contract; will buy ADL Technology
-
LSI Industries Inc. Announces (1) Major National LED Crossover(r) Program and (2)...
Industry Transcripts by Seeking Alpha
-
Avanir Pharmaceuticals F4Q09 (Qtr End 09/30/2009) Earnings Call Transcript
on Nov 24, 2009about AVNR
-
Palatin Technologies F1Q10 (Qtr End 9/30/09) Earnings Call Transcript
on Nov 16, 2009about PTN
-
Flamel Technologies SA Q3 2009 Earnings Call Transcript
on Nov 16, 2009about FLML
-
NexMed Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about NEXM
-
InterMune, Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about ITMN
Glass Door
Meridian Bioscience
IndustryTop Rated
- How NOT to Write a Biotech Press Release: Just Ask Epeius 5 votes
- Why J&J's Stelara Launch Should Target Dermatologists First 3 votes
- Teva, In Turnabout, Sues to Protect Its Multiple Sclerosis Drug Copaxone 3 votes
- Fired Whistleblower Reps Make Similar Claim: Pfizer Said They Lacked "Integrity" 3 votes
- VeriChip TV Ad Confirms Critics' Fears: They Want Everyone Implanted 3 votes

